Effects of Hyperhomocysteinemia on Non-adrenergic Non-cholinergic Relaxation in Isolated Rat Duodenum

Overview

Journal Dig Dis Sci

Specialty Gastroenterology

Date 2008 Jun 7

PMID 18535907

Authors

Edibe Karasu

Gulay Sadan

Arda Tasatargil

Affiliations

Soon will be listed here.

Abstract

The effect of hyperhomocysteinemia induced by pretreatment with methionine 12 weeks prior to the study on the responses induced by gamma-aminobutyric acid (GABA), electrical field stimulation (EFS), and ATP have been evaluated in isolated rat duodenum. In the presence of adrenergic and cholinergic blockade, EFS (60 V, 1 ms, 1-3 Hz) induced frequency-dependent relaxations of the preparation. GABA and ATP also caused submaximal relaxation of the rat duodenum. The relaxations induced by GABA, EFS, and ATP were not significantly changed in duodenal tissues from hyperhomocysteinemic rats compared with control rats. GABA- and EFS-induced relaxations were inhibited by N-nitro-L-arginine methyl ester (L-NAME; 3 x 10(-4) M) in both hyperhomocysteinemic and control rats. On the other hand, L-NAME incubation did not affect ATP-induced relaxation. These results suggest that hyperhomocysteinemia does not cause an important impairment on non-adrenergic non-cholinergic innervation of the rat duodenum.

References

Tasatargil A, Sadan G, Karasu E . Homocysteine-induced changes in vascular reactivity of guinea-pig pulmonary arteries: role of the oxidative stress and poly (ADP-ribose) polymerase activation. Pulm Pharmacol Ther. 2006; 20(3):265-72. DOI: 10.1016/j.pupt.2006.02.004. View

MALINOW M, Kang S, Taylor L, Wong P, Coull B, INAHARA T . Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease. Circulation. 1989; 79(6):1180-8. DOI: 10.1161/01.cir.79.6.1180. View

Mourelle M, Guarner F, Moncada S, Malagelada J . The arginine/nitric oxide pathway modulates sphincter of Oddi motor activity in guinea pigs and rabbits. Gastroenterology. 1993; 105(5):1299-305. DOI: 10.1016/0016-5085(93)90132-v. View

Stampfer M, MALINOW M . Can lowering homocysteine levels reduce cardiovascular risk?. N Engl J Med. 1995; 332(5):328-9. DOI: 10.1056/NEJM199502023320511. View

Koutroubakis I, Dilaveraki E, Vlachonikolis I, Vardas E, Vrentzos G, Ganotakis E . Hyperhomocysteinemia in Greek patients with inflammatory bowel disease. Dig Dis Sci. 2001; 45(12):2347-51. DOI: 10.1023/a:1005583606647. View

Romagnuolo J, Fedorak R, Dias V, Bamforth F, Teltscher M . Hyperhomocysteinemia and inflammatory bowel disease: prevalence and predictors in a cross-sectional study. Am J Gastroenterol. 2001; 96(7):2143-9. DOI: 10.1111/j.1572-0241.2001.03950.x. View

Seshadri S, Beiser A, Selhub J, Jacques P, Rosenberg I, DAgostino R . Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med. 2002; 346(7):476-83. DOI: 10.1056/NEJMoa011613. View

Burnstock G, Campbell G, Rand M . The inhibitory innervation of the taenia of the guinea-pig caecum. J Physiol. 1966; 182(3):504-26. PMC: 1357484. DOI: 10.1113/jphysiol.1966.sp007834. View

de Bree A, Verschuren W, Kromhout D, Kluijtmans L, Blom H . Homocysteine determinants and the evidence to what extent homocysteine determines the risk of coronary heart disease. Pharmacol Rev. 2002; 54(4):599-618. DOI: 10.1124/pr.54.4.599. View

10.

Tasatargil A, Sadan G, Karasu E, Ozdem S . Changes in atrium and thoracic aorta reactivity to adenosinergic and adrenergic agonists in experimental hyperhomocysteinemia. J Cardiovasc Pharmacol. 2006; 47(5):673-9. DOI: 10.1097/01.fjc.0000211756.31820.17. View

11.

Tasatargil A, Sadan G, Golbasi I, Karasu E, Turkay C . Effects of short-term exposure to homocysteine on vascular responsiveness of human internal mammary artery. J Cardiovasc Pharmacol. 2004; 43(5):692-7. DOI: 10.1097/00005344-200405000-00012. View

12.

Kaputlu I, Sadan G . Evidence that nitric oxide mediates non-adrenergic non-cholinergic relaxation induced by GABA and electrical stimulation in the rat isolated duodenum. J Auton Pharmacol. 1996; 16(4):177-82. DOI: 10.1111/j.1474-8673.1996.tb00420.x. View

13.

Takahashi T . Pathophysiological significance of neuronal nitric oxide synthase in the gastrointestinal tract. J Gastroenterol. 2003; 38(5):421-30. DOI: 10.1007/s00535-003-1094-y. View

14.

Sanders K, Ward S . Nitric oxide as a mediator of nonadrenergic noncholinergic neurotransmission. Am J Physiol. 1992; 262(3 Pt 1):G379-92. DOI: 10.1152/ajpgi.1992.262.3.G379. View

15.

Krantis A, Mattar K, Glasgow I . Rat gastroduodenal motility in vivo: interaction of GABA and VIP in control of spontaneous relaxations. Am J Physiol. 1998; 275(5):G897-903. DOI: 10.1152/ajpgi.1998.275.5.G897. View

16.

Gustafsson B, Delbro D . Tonic inhibition of small intestinal motility by nitric oxide. J Auton Nerv Syst. 1993; 44(2-3):179-87. DOI: 10.1016/0165-1838(93)90030-x. View

17.

Nichols K, Krantis A, Staines W . Histochemical localization of nitric oxide-synthesizing neurons and vascular sites in the guinea-pig intestine. Neuroscience. 1992; 51(4):791-9. DOI: 10.1016/0306-4522(92)90520-c. View

18.

Lentz S, Sobey C, Piegors D, Bhopatkar M, Faraci F, MALINOW M . Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia. J Clin Invest. 1996; 98(1):24-9. PMC: 507396. DOI: 10.1172/JCI118771. View

19.

Windscheif U, Pfaff O, Ziganshin A, Hoyle C, Baumert H, Mutschler E . Inhibitory action of PPADS on relaxant responses to adenine nucleotides or electrical field stimulation in guinea-pig taenia coli and rat duodenum. Br J Pharmacol. 1995; 115(8):1509-17. PMC: 1908869. DOI: 10.1111/j.1476-5381.1995.tb16644.x. View

20.

Oldenburg B, Fijnheer R, van der Griend R, vanBerge-Henegouwen G, Koningsberger J . Homocysteine in inflammatory bowel disease: a risk factor for thromboembolic complications?. Am J Gastroenterol. 2000; 95(10):2825-30. DOI: 10.1111/j.1572-0241.2000.03193.x. View